• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利人群中XRCC1基因Arg399Gln多态性与肝细胞癌风险

XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.

作者信息

Santonocito Concetta, Scapaticci Margherita, Nedovic Bojan, Annicchiarico Eleonora B, Guarino Donatella, Leoncini Emanuele, Boccia Stefania, Gasbarrini Antonio, Capoluongo Ettore

机构信息

Laboratory of Clinical Molecular Biology, Department of Biochemistry & Clinical Biochemistry, Catholic University of the Sacred Heart, Rome - Italy.

Department of Internal Medicine, A. Gemelli Teaching Hospital, Catholic University of the Sacred Heart, Rome - Italy.

出版信息

Int J Biol Markers. 2017 May 4;32(2):e190-e194. doi: 10.5301/jbm.5000241.

DOI:10.5301/jbm.5000241
PMID:28058700
Abstract

BACKGROUND

The human X-ray repair cross-complementing protein 1 (XRCC1) gene encodes for one of the major repair factors involved in base excision repair (BER), which is reported to be associated with the risk of several cancers. A few studies have explored the association between risk of hepatocellular carcinoma (HCC) and single-nucleotide polymorphisms (SNPs) in different DNA repair genes, with contradictory results. The purpose of this study was to evaluate the association between XRCC1 Arg399Gln polymorphism and susceptibility to HCC.

METHODS

A total of 89 HCC patients and 99 randomly selected healthy controls were enrolled. Genotyping of XRCC1 rs25487 was performed by high-resolution melting analysis and Sanger sequencing.

RESULTS

On univariate analysis, a statistically significant association was found between risk of HCC and XRCC1 399Arg/Gln genotype (odd ratio [OR] = 1.88; 95% CI, 1.04-3.43), which was confirmed after adjusting by sex (OR = 1.94; 95% CI, 1.04-3.63). Although not significant, Kaplan-Meier analysis showed a decreased median survival in Arg/Gln genotype carriers in comparison with Arg/Arg carriers.

CONCLUSIONS

To our knowledge, this is the first study reporting an association between BER SNP and HCC risk in a population of central-southern Italy.

摘要

背景

人类X射线修复交叉互补蛋白1(XRCC1)基因编码参与碱基切除修复(BER)的主要修复因子之一,据报道该因子与多种癌症的风险相关。一些研究探讨了不同DNA修复基因中的单核苷酸多态性(SNP)与肝细胞癌(HCC)风险之间的关联,但结果相互矛盾。本研究的目的是评估XRCC1 Arg399Gln多态性与HCC易感性之间的关联。

方法

共纳入89例HCC患者和99例随机选择的健康对照。通过高分辨率熔解分析和桑格测序对XRCC1 rs25487进行基因分型。

结果

单因素分析发现,HCC风险与XRCC1 399Arg/Gln基因型之间存在统计学显著关联(比值比[OR]=1.88;95%置信区间,1.04-3.43),经性别调整后得到证实(OR=1.94;95%置信区间,1.04-3.63)。虽然不显著,但Kaplan-Meier分析显示,与Arg/Arg携带者相比,Arg/Gln基因型携带者的中位生存期缩短。

结论

据我们所知,这是第一项报道意大利中南部人群中BER SNP与HCC风险之间存在关联的研究。

相似文献

1
XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.意大利人群中XRCC1基因Arg399Gln多态性与肝细胞癌风险
Int J Biol Markers. 2017 May 4;32(2):e190-e194. doi: 10.5301/jbm.5000241.
2
Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.DNA修复基因XRCC1多态性在预测肝细胞癌风险及预后中的评估
Asian Pac J Cancer Prev. 2012;13(1):191-4. doi: 10.7314/apjcp.2012.13.1.191.
3
XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.XRCC1基因Arg399Gln多态性与肝细胞癌风险:一项荟萃分析
Mol Biol Rep. 2014 Feb;41(2):879-87. doi: 10.1007/s11033-013-2929-0. Epub 2014 Jan 4.
4
Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.三种 XRCC1 多态性与肝细胞癌风险的关联:病例对照研究的荟萃分析。
PLoS One. 2018 Nov 8;13(11):e0206853. doi: 10.1371/journal.pone.0206853. eCollection 2018.
5
Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.东亚人群中DNA修复基因XRCC1多态性与肝细胞癌风险的Meta分析
Tumour Biol. 2013 Feb;34(1):261-9. doi: 10.1007/s13277-012-0546-5. Epub 2012 Oct 6.
6
Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.DNA修复基因XRCC1和XRCC3多态性在预测肝细胞癌风险及预后中的研究
Hepatogastroenterology. 2012 Oct;59(119):2285-9. doi: 10.5754/hge12096.
7
Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.XPD和XRCC1基因多态性与肝细胞癌风险的关联。
Asian Pac J Cancer Prev. 2012;13(9):4423-6. doi: 10.7314/apjcp.2012.13.9.4423.
8
Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.X射线修复交叉互补蛋白1(XRCC1)的基因变异与慢性丙型肝炎患者肝细胞癌的风险
Br J Biomed Sci. 2019 Apr;76(2):64-69. doi: 10.1080/09674845.2019.1594487. Epub 2019 Apr 26.
9
An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.关于X射线修复交叉互补基因1第399位密码子多态性与肝细胞癌风险关联的最新荟萃分析。
Asian Pac J Cancer Prev. 2014;15(11):4443-8. doi: 10.7314/apjcp.2014.15.11.4443.
10
Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.DNA修复基因多态性对肝细胞癌预后的影响
Asian Pac J Cancer Prev. 2013;14(1):355-8. doi: 10.7314/apjcp.2013.14.1.355.

引用本文的文献

1
Exploring Hepatocellular Carcinoma Pathogenesis: The Influence of Genetic Polymorphisms.探索肝细胞癌发病机制:基因多态性的影响
Curr Pharm Des. 2025;31(6):432-442. doi: 10.2174/0113816128327773240827062719.
2
Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population.对中国汉族慢性乙型肝炎病毒感染相关肝细胞癌中MMR基因的综合研究。
Front Oncol. 2023 Mar 24;13:1124459. doi: 10.3389/fonc.2023.1124459. eCollection 2023.
3
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma.
肝细胞癌耐药性的分子基础
Cancers (Basel). 2020 Jun 23;12(6):1663. doi: 10.3390/cancers12061663.
4
A Comprehensive Evaluation of the Association between Polymorphisms in , , and and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis.对 、 和 基因多态性与肝细胞癌预后之间关联的综合评估:一项荟萃分析。
J Oncol. 2019 Jun 12;2019:2408946. doi: 10.1155/2019/2408946. eCollection 2019.
5
Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma.干扰素诱导跨膜蛋白3基因rs12252-CC与肝细胞癌的低分化和进展相关。
Medicine (Baltimore). 2019 Jan;98(2):e13996. doi: 10.1097/MD.0000000000013996.
6
Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.三种 XRCC1 多态性与肝细胞癌风险的关联:病例对照研究的荟萃分析。
PLoS One. 2018 Nov 8;13(11):e0206853. doi: 10.1371/journal.pone.0206853. eCollection 2018.